WHO Pharmaceuticals Newsletter 2004, No. 01
(2004; 17 pages) View the PDF document
Table of Contents
Open this folder and view contentsREGULATORY MATTERS
Close this folderSAFETY OF MEDICINES
View the documentANTIEPILEPTICS - ADR update from Australia
View the documentBOTULINUM TOXIN TYPE A - Place in therapy not clearly defined
View the documentCELECOXIB/ROFECOXIB - Acute temporary visual impairment
View the documentDACLIZUMAB - Increased mortality in cardiac transplant patients
View the documentFLUTICASONE - Update on adrenal insufficiency reports
View the documentINTERFERON BETA - Safety information about risk of liver injury
View the documentMETHADONE - Risk of QT prolongation
View the documentMETHOTREXATE - Update on pulmonary effects
View the documentMIRTAZAPINE - ADR update from Australia
View the documentMORPHINE - Accidental overdose of concentrated oral solutions
View the documentNONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) - Postpartum administration may cause hypertension
View the documentPERGOLIDE - Danger of falling asleep during daily activities
View the documentPYRAZINAMIDE & RIFAMPICIN - Serious liver injury with combined use in latent tuberculosis
View the documentSIBUTRAMINE - ADR update
View the documentTOPIRAMATE - Warning about metabolic acidosis
View the documentWARFARIN - Interaction with cranberry juice
Open this folder and view contentsDRUGS OF CURRENT INTEREST
Open this folder and view contentsFEATURE
 

NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) - Postpartum administration may cause hypertension

Australia. The Adverse Drug Reactions Advisory Committee (ADRAC) has recently received six reports of hypertension or hypertensive crisis in women following the postpartum administration of NSAIDs (indometacin, ibuprofen or diclofenac). Four of the women had a history of pre-eclampsia, one of whom died of hypertensive crisis and intracranial haemorrhage after undergoing a Caesarian section. The other two women, including one who experienced an eclamptic seizure, had no prior history of hypertension. Only two of the women were receiving anti-hypertensive therapy at the time of the adverse event. The committee suggests that the severe hypertension in the reported cases may have been caused by the patients' underlying condition, but that it is plausible that NSAID administration made a significant contribution. ADRAC advises careful monitoring of blood pressure in women (with a history of pre-eclampsia or essential hypertension) administered NSAIDs in the postpartum period.

Reference:
Reactions 980: 2, 6 December 2003.

to previous section to next section
 

Last updated: May 3, 2013